PrEP: latest news

PrEP resources

  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • First year Amsterdam PrEP project complete

    Last year the Public Health Service of Amsterdam (GGD) started the Amsterdam PrEP project, a research project focused on the applicability of PrEP for HIV prevention among men who have sex with men (MSM) and transgender individuals. We now have a picture of the first 200 participants and of national developments over the past year. Almost three-quarters of participants preferred daily PrEP to event-based use (before and after sex). PrEP protected almost all participants from HIV. Two participants contracted an HIV infection in the past year. (To read the press release in English, click the link on the right-hand side of the page).

    17 hours ago | GGD Amsterdam
  • Report recommends PrEP for use in Scotland

    Last week, a report recommending PrEP for use in Scotland was endorsed by the Executive Leads Network, who govern Scotland's Sexual Health and Blood Borne Virus Framework. The report was written by the Scottish HIV PrEP Short Life Working Group (SLWG), administered by HIV Scotland and chaired by Dr Rak Nandwani.

    19 hours ago | HIV Scotland
  • Norway to provide free HIV-preventing PrEP drugs to at-risk gay men

    Norway has this week become the second country in Europe to make PrEP available, announcing that PrEP drugs will be available free of charge to at-risk groups via its National Health Scheme. According to HIV Norway, Minister for Health and Social Care Bent Høie announced the move, making Norway the first country in Europe to make the drug completely free for users (French users have to pay a small and largely reimbursible upfront fee.)

    21 October 2016 | Pink News
  • NHS Under Pressure To Explain “Homophobic” Response To HIV Drug Ruling

    NHS England is facing calls from leading HIV charities and a Conservative MP to explain why it heavily edited a press statement on a court ruling about an HIV prevention drug to include lines that have been described as “homophobic” and “irresponsible”.

    21 October 2016 | BuzzFeed
  • European delays on HIV prevention drug endanger gay men and others at risk of HIV

    A new report, PrEP Access in Europe, by the PrEP in Europe Initiative, a coalition of leading HIV organisations, calls on European governments and health authorities to make PrEP (pre-exposure prophylaxis) available to populations at imminent risk of HIV as a matter of urgency.

    18 October 2016 | NAT press release
  • Gilead Begins Major Clinical Trial of Descovy vs. Truvada as PrEP

    Gilead Sciences has begun a major trial to compare the efficacy of Descovy (emtricitabine/tenofovir alafenamide, or TAF) versus Truvada (tenofovir disoproxil fumarate, or TDF/emtricitabine) as pre-exposure prophylaxis (PrEP) against HIV.

    14 October 2016 | Poz
  • PrEP Gives Us More

    Jim Pickett of the AIDS Foundation of Chicago: "PrEP has altered the landscape in HIV prevention in extraordinary and profound ways. It’s changing the lives of vulnerable individuals. It’s also bringing about big changes for the HIV workforce—health care providers, prevention specialists, outreach workers, social workers, educators and more. In fact, I believe we’ve entered the most dynamic period in our fight against HIV since 1996."

    13 October 2016 | ETR
  • How to find a PrEP doctor in your area

    Want to find out more about PrEP, and if it’s right for you, but not sure where to get services? Researchers from the Rollins School of Public Health at Emory School of Public Health at Emory University recently published a searchable, online directory of PrEP providers across the United States.

    13 October 2016 | BETA blog
  • Drug watchdog ‘confirms case’ for HIV-preventing drugs on the NHS

    The UK’s drug watchdog NICE has today released a review of HIV-preventing drugs amid a legal battle on the issue.

    06 October 2016 | Pink News
  • Most gay men not aware of treatment to protect them from HIV

    Only four in 10 gay and bisexual men in Baltimore without HIV are aware that pre-exposure prophylaxis medication (PrEP) may significantly reduce their risk of contracting the virus, even those who had recently visited a doctor or been tested for a sexually transmitted disease, new Johns Hopkins Bloomberg School of Public Health research suggests.

    05 October 2016 | Eurekalert Medicine & Health
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap